According to a new study from the National Institutes of Health ( NIH ), medications for attention deficit hyperactive disorder (ADHD) do not appear to cause genetic damage.

Researchers have discovered markers for measuring the ability of children with Attention Deficit Hyperactivity Disorder to control impulsive movements.

The health of a baby in the first five minutes of exiting the womb may be associated with his or her risk of developing attention-deficit hyperactivity disorder (ADHD).